Top of the Street: SOBI, Sonova, BAT, Imperial Brands
BUZZ-Top of the Street: SOBI, Sonova, BAT, Imperial Brands Nov 10 (Reuters) - A round-up of notable broker activity this morning from Europe’s top-ranked* analysts:
** Jefferies upgrades Swiss hearing aid maker Sonova SOON.S to "hold" from "underperform", citing better market conditions and encouraging early feedback on new products. It raises its PT by 62% to CHF 275.
** Deutsche Bank cuts Swedish biopharmaceutical company SOBI SOBIV.ST to "hold" from "buy", citing Ionis' lowered Tryngolza sales forecast
INITIATIONS AND REINSTATEMENTS
** JPMorgan reinstates coverage of British tobacco group BAT BATS.L with "overweight" and a PT of 5,300p.
** It also reinstates coverage of peer Imperial Brands IMB.L with "neutral" and a PT of 3,200p.
(*Analyst rankings from Thomson Reuters StarMine. The scale is from 1-star to 5-star with 5 being the best. Analysts are ranked on earnings accuracy as well as relative performance of recommendations over trailing 12-month & 24-month periods.)
(Reporting by Leo Marchandon and Boleslaw Lasocki in Gdansk)
Recent news on Swedish Orphan Biovitrum AB (publ)
See all newsTop of the Street: SOBI, Sonova, BAT, Imperial Brands
SOBI slips after Ionis lowers Tryngolza sales forecast
Brief: Swedish Orphan Biovitrum Executive Sells, Buys Shares
Europe Research Roundup: Centrica, Fuchs, URW
Brief: Swedish Orphan Biovitrum Proposes Börje Ekholm As New Chair And Board Member At 2027 AGM